Last quarter (Q3 2023), Hisamitsu Pharmaceutical Co's total revenue was $32.26B, an increase of 14.76% from the same quarter last year. In Q3, Hisamitsu Pharmaceutical Co's net income was $3.02B. See Hisamitsu Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Feb 22	Feb 21	Feb 20	Feb 19	Feb 18
Total Revenue	$ 125.41B	$ 120.19B	$ 114.51B	$ 140.99B	$ 143.41B	$ 148.47B
Cost of Revenue	$ 54.34B	$ 50.13B	$ 45.34B	$ 53.39B	$ 54.73B	$ 55.69B
Gross Profit	$ 71.07B	$ 70.07B	$ 69.17B	$ 87.60B	$ 88.68B	$ 92.78B
Operating Expense	$ 60.20B	$ 60.73B	$ 58.50B	$ 64.88B	$ 66.40B	$ 65.84B
Operating Income	$ 10.87B	$ 9.34B	$ 10.67B	$ 22.73B	$ 22.28B	$ 26.94B
Net Non Operating Interest Income Expense	$ 420.00M	$ 133.00M	$ 553.00M	$ 1.12B	$ 781.00M	$ 461.00M
Other Income Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Pretax Income	$ 16.99B	$ 12.96B	$ 12.20B	$ 26.16B	$ 25.67B	$ 27.69B
Tax Provision	$ 3.74B	$ 3.09B	$ 2.76B	$ 7.24B	$ 6.29B	$ 8.37B
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ 12.96B	$ 9.66B	$ 9.25B	$ 18.69B	$ 19.20B	$ 19.12B
Basic EPS	$ 162.24	$ 118.92	$ 113.22	$ 227.58	$ 230.08	$ 228.52
Diluted EPS	$ 162.11	$ 118.84	$ 113.11	$ 227.30	$ 229.86	$ 228.35
Basic Average Shares	$ 318.96M	$ 81.21M	$ 81.71M	$ 82.14M	$ 83.47M	$ 83.67M
Diluted Average Shares	$ 319.25M	$ 81.27M	$ 81.78M	$ 82.24M	$ 83.55M	$ 83.73M
Dividend Per Share	$ 84.00	$ 84.00	$ 83.50	$ 83.00	$ 41.25	$ 41.00
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 114.54B	$ 110.86B	$ 103.84B	$ 118.26B	$ 121.13B	$ 121.52B
Net Income From Continuing And Discontinued Operation	$ 12.96B	$ 9.66B	$ 9.25B	$ 18.69B	$ 19.20B	$ 19.12B
Normalized Income	$ 12.95B	$ 9.42B	$ 9.15B	$ 18.31B	$ 18.43B	$ 19.50B
Interest Expense	$ 21.00M	$ 20.00M	$ 10.00M	$ 19.00M	$ 19.00M	$ 32.00M
EBIT	$ 17.01B	$ 12.98B	$ 12.21B	$ 26.17B	$ 25.69B	$ 27.73B
EBITDA	$ 17.01B	$ 17.30B	$ 16.29B	$ 30.43B	$ 31.43B	$ 33.73B

Currency in USD

Hisamitsu Pharmaceutical Co Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing